iBio Appoints James Abbey, Ph.D. as Vice President of Strategic Business Development
October 02, 2017 08:30 ET
|
iBio, Inc.
NEW YORK, Oct. 02, 2017 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, announced today the...
iBio, Inc. Intellectual Property Update
September 20, 2017 08:00 ET
|
iBio, Inc.
NEW YORK, Sept. 20, 2017 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, provided an update...
iBio Makes NYSE MKT Section 610(b) Public Announcement
September 19, 2017 17:55 ET
|
iBio, Inc.
NEW YORK, Sept. 19, 2017 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO) – iBio, a leader in developing plant-based biopharmaceuticals, today announced that, as previously disclosed in its...
iBio and TheoremDx Collaborate to Develop Proteins for Rapid Diagnostics Testing Products
September 18, 2017 08:00 ET
|
iBio, Inc.
NEW YORK, Sept. 18, 2017 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO) – iBio, with its subsidiary, iBio CDMO LLC in Bryan/College Station, Texas ("iBio CDMO"), has partnered with TheoremDx,...
iBio, Inc. Enters into Common Stock Purchase Agreement for Up to $16.0 Million with Lincoln Park Capital
July 24, 2017 08:30 ET
|
iBio, Inc.
NEW YORK, July 24, 2017 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE MKT:IBIO) (“iBio”), a leader in developing plant-based biopharmaceuticals, announced today that it has entered into a $16 million common...
iBio, Inc. to Present Plant-Made Pharmaceutical Platform at Plant-Based Vaccines, Antibodies & Biologics Conference
June 05, 2017 08:30 ET
|
iBio, Inc.
NEW YORK, June 05, 2017 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE MKT:IBIO), a leader in developing plant-based biopharmaceuticals, announced today that Barry Holtz, PhD, President of iBio CMO LLC is...
iBio, Inc. Provides Corporate Update at Annual Shareholders Meeting
May 04, 2017 16:01 ET
|
iBio, Inc.
NEW YORK, NY--(Marketwired - May 4, 2017) - iBio, Inc. (NYSE MKT: IBIO), a leader in developing plant-based biopharmaceuticals, announced today that it provided a corporate update at its Annual...
Court Schedules Hearing To Consider Approval Of Settlement Of Derivative Action
January 27, 2017 08:30 ET
|
iBio, Inc.
NEW YORK, NY--(Marketwired - Jan 27, 2017) - iBio, Inc. (NYSE MKT: IBIO) On January 20, 2017, the Supreme Court for the State of New York, County of New York, scheduled a hearing to consider...
Another iBio Plague Vaccine Patent Issues
November 21, 2016 08:31 ET
|
iBio, Inc.
NEW YORK, NY--(Marketwired - Nov 21, 2016) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, announced the issue of...
iBio Expands Product Development Capacity of cGMP Plant
November 10, 2016 08:31 ET
|
iBio, Inc.
NEW YORK, NY--(Marketwired - Nov 10, 2016) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, announced completion...